Docetaxel in combination carboplatin as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer

被引：0
|
作者：
Barata, F
Camacho, E
Sousa, A
Costa, MS
Resende, R
Meleiro, A
Nogueira, F
Pereira, A
Canário, D
机构：
[1] Ctr Hosp Coimbra, Coimbra, Portugal
[2] Hosp Nossa Senhora Rosario, Barreiro, Portugal
[3] Hosp Univ Coimbra, Coimbra, Portugal
[4] Hosp Distrital Santarem, Santarem, Portugal
[5] Hosp Amato Lusitano, Castelo Branco, Portugal
[6] Hosp S Bernardo, Setubal, Portugal
[7] Hosp Egas Moniz, Lisbon, Portugal
[8] Hosp Distrital Fig Foz, Figueira Foz, Portugal
[9] Hosp Garcis Orta, Almada, Portugal
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [41] A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer
    Pallis, Athanasios G.
    Agelaki, Sophia
    Agelidou, Athina
    Varthalitis, Ioannis
    Syrigos, Kostas
    Kentepozidis, Nikolaos
    Pavlakou, Georgia
    Kotsakis, Athanasios
    Kontopodis, Emmanouel
    Georgoulias, Vassilis
    BMC CANCER, 2010, 10
  • [42] Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer
    Horvath, L
    Boyer, M
    Clarke, S
    Beale, P
    Beith, J
    Underhill, C
    Stockler, M
    Bishop, J
    LUNG CANCER, 2001, 32 (02) : 173 - 178
  • [43] Docetaxel and gemcitabine combination as first-line treatment in advanced or metastatic non-small-cell lung cancer: A multicenter phase II study
    Costa, A
    Almodovar, T
    Seada, J
    Barata, F
    Teixeira, E
    Queiroga, H
    Pires, S
    PROCEEDINGS OF THE 9TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2004, : 117 - 120
  • [44] The cost effectiveness of penpulimab with paclitaxel and carboplatin in first-line treatment of metastatic squamous non-small cell lung cancer
    Kaiqi Zhu
    Zhaoyi Pan
    Mengyao Qin
    Jin Huang
    Scientific Reports, 15 (1)
  • [45] Docetaxel in combination with cisplatin for first-line treatment of locally advanced or metastasic non-small cell lung cancer:: meta-analysis of randomized and controlled clinical trials
    Lerma, BS
    Sánchez, IP
    Grima, FG
    MEDICINA CLINICA, 2004, 122 (08): : 281 - 287
  • [46] The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected locally advanced non-small cell lung cancer
    Sun, Hai-bo
    Wang, Si-yu
    Ou, Wei
    Zhang, Bin-bin
    Yang, Hua
    Fang, Qin
    LUNG CANCER, 2010, 68 (03) : 403 - 408
  • [47] The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected locally advanced non-small cell lung cancer
    Wang Si-yu
    Sun Haibo
    Zhang Bin-bin
    Ou Wei
    Yang Hua
    Fang Qin
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S791 - S792
  • [48] COST COMPARISON OF ERLOTINIB VERSUS PEMETREXED FOR THE FIRST-LINE MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN SPAIN
    Castro de Carpeno, J.
    Castro-Gomez, A. J.
    Walzer, S.
    Ray, J.
    VALUE IN HEALTH, 2010, 13 (07) : A259 - A259
  • [49] A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer
    Pilkington, Gerlinde
    Boland, Angela
    Brown, Tamara
    Oyee, James
    Bagust, Adrian
    Dickson, Rumona
    THORAX, 2015, 70 (04) : 359 - 367
  • [50] Atezolizumab in combination with bevacizumab, paclitaxel and carboplatin for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, including patients with EGFR mutations
    Reck, Martin
    Shankar, Geetha
    Lee, Anthony
    Coleman, Shelley
    McCleland, Mark
    Papadimitrakopoulou, Vassiliki A.
    Socinski, Mark A.
    Sandler, Alan
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (02) : 125 - 136
12345